Skip to search formSkip to main contentSkip to account menu

Milligram per Square Meter per Day

Known as: Milligram per Square Meter per 24 Hours, mg/m2/d, Milligram/meter2/day 
A dose calculation unit expressed in milligram(s) per square meter per period of time equal to twenty-four hours.
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM).
2023 Background: The prognosis for newly diagnosed GBM remains poor. The addition of TMZ to radiation therapy improved the median… 
2007
2007
Tolerability and hematologic improvement assessed using three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes
7083 Background: At a dosing schedule of 75 mg/m2/day SC for 7 days every 4 weeks, azacitidine is an effective and safe treatment… 
1994
1994
Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II study
Background. Etoposide displays remarkable schedule dependency. To better define the optimal dose and schedule, the authors… 
Highly Cited
1993
Highly Cited
1993
Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.
PURPOSE Prompted by recent demonstrations that all-trans-retinoic acid (all-trans-RA) had efficacy in acute promyelocytic… 
1991
1991
Remises en suspension sédimentaires observées en Méditerranée par 2 000 m de profondeur à l'aide de pièces à particules
Philippe CRASSOUS •, Alexis KHRIPOUNOFF •, Jacques LA ROSA b, Juan-Carlos MIQUEL b • Institut Francais de Recherche pour l… 
1986
1986
Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Menogaril, a semisynthetic derivative of nogalomycin, was brought to phase I clinical testing in patients with refractory solid… 
1982
1982
Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Thirty patients were entered in a phase I trial of aziridinylbenzoquinone (AZQ). These patients were treated with a single iv… 
1982
1982
A phase I trial of aziridinylbenzoquinone (NSC 182986) in patients with previously treated acute leukemia
Twenty-TWO ADULT PATIENTS with relapsed leukemia were given aziridinylbenzoquinone (AZQ) intravenously in a phase I clinical… 
1982
1982
Phase I trial and pharmacokinetics of a daily x 5 schedule of 3-deazauridine.
The uridine analog 3-deazauridine has been given to 19 patients in a phase I and pharmacokinetic study. Only mild toxicity was… 
1981
1981
Phase I trial of dihydroxyanthracenedione.
Dihydroxanthracenedione was given to 16 patients with solid tumors in a phase I clinical trial. The dose schedule used was a…